-

08:14:58 AM

LIVE Real Time CSII Stock Market News

CSII - Cardiovascular Systems Inc.

04/15/21 7:00 PM

Nasdaq : CSII

Cardiovascular Systems, Inc. to Webcast Fiscal 2021 Third-Quarter Earnings Conference Call Thursday, May 6

Cardiovascular Systems, Inc. (CSI (R)) (NASDAQ: CSII) will host a live webcast of its fiscal 2021 third-quarter conference call on Thursday, May 6, 2021, at 3:30 p.m. CT (4:30 p.m. ET). CSI management will discuss results for its fiscal third quarter ended March 31, 2021, and its financial outlook.

RHEA-AI

neutral

04/08/21 7:00 AM

Nasdaq : CSII

Cardiovascular Systems, Inc. Announces Investment and Acquisition Option Agreement With Telehealth Company, CarePICS, LLC

Cardiovascular Systems, Inc. (CSI (R)) (NASDAQ: CSII) announced today that it has completed a minority investment and entered into an acquisition option agreement with CarePICS, LLC (CarePICS (R)), a telehealth company offering a virtual care platform designed to improve the outcomes of patients

RHEA-AI

neutral

03/24/21 7:00 AM

Nasdaq : CSII

Cardiovascular Systems, Inc. to Participate at the 20th Annual Needham Healthcare Conference

Cardiovascular Systems, Inc. (CSI (R) ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced that management plans to present and host investor meetings at the 20

RHEA-AI

neutral

03/22/21 9:00 AM

Nasdaq : CSII

Cardiovascular Systems, Inc. Announces Acquisition of Peripheral Support Catheters From WavePoint Medical, LLC

Cardiovascular Systems, Inc. (CSI (R)) (NASDAQ: CSII) announced today that it has acquired a line of peripheral support catheters from WavePoint Medical, LLC.Peripheral support catheters are used during peripheral vascular intervention (PVI) procedures for guidewire support to enable lesion

RHEA-AI

neutral

03/17/21 7:00 AM

Nasdaq : CSII

Cardiovascular Systems, Inc. Announces First Uses of WIRION(R) Embolic Protection System

Cardiovascular Systems, Inc. (CSI (R) ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that the first patients in the U.S. have been treated with the WIRION (R)

RHEA-AI

neutral

02/11/21 7:00 AM

Nasdaq : CSII

Cardiovascular Systems, Inc. to Participate at Four Upcoming Investor Conferences

Cardiovascular Systems, Inc. (CSI (R) ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced that management plans to present and host investor meetings at three

RHEA-AI

neutral

02/08/21 4:05 PM

Nasdaq : CSII

First Patient in Europe Treated With Cardiovascular Systems, Inc. Diamondback 360(R) Coronary Orbital Atherectomy System

Cardiovascular Systems, Inc. (CSI (R) ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that the first patient in Europe has been treated with its Diamondback

RHEA-AI

positive

02/03/21 4:05 PM

Nasdaq : CSII

Cardiovascular Systems, Inc. Reports Fiscal 2021 Second-quarter Financial Results

Cardiovascular Systems, Inc. (CSI (R) ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today reported financial results for its fiscal second quarter, ended December 31,

RHEA-AI

neutral

02/01/21 7:00 AM

Nasdaq : CSII

Cardiovascular Systems, Inc. Announces Partnership With Chansu Vascular Techologies, LLC to Develop New Drug-Coated Balloon Technology

Cardiovascular Systems, Inc. (CSI (R)) (NASDAQ: CSII) announced today that it has partnered with Chansu Vascular Technologies, LLC (CVT) to develop novel peripheral and coronary everolimus drug-coated balloons (DCBs). This partnership brings together CSI's leadership in the treatment of calcified

RHEA-AI

very positive

01/27/21 5:00 PM

Nasdaq : CSII

Cardiovascular Systems, Inc. Announces Sachin H. Jain, MD, MBA, Joins Board of Directors

Cardiovascular Systems, Inc. (CSI (R) ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced the addition of independent board member Sachin H. Jain, MD, MBA.Dr.

RHEA-AI

neutral